Results 131 to 140 of about 98,354 (197)

In vitro and in vivo evaluation of the leishmanicidal and cytotoxic activities of chitosan and chitosan-amphotericin B. [PDF]

AMB Express
Mousavi P, Rahimi Esboei B, Pourhajibagher M, Zolfaghari A, Shahmoradi Z, Namdar F, Ahmadi S, Mousavi SM, Parandin F, Hejazi SH.   +9 more
europepmc   +1 more source

HIV protease inhibitors restore amphotericin B activity against Candida. [PDF]

PLoS One
Elgammal Y, Salama EA, Seleem MN.
europepmc   +1 more source

Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.

, 1998
J D Berman, Roberto Badaró, C.P. Thakur, K. Wasunna, K. Behbehani, R.N. Davidson, F. A. S. Kuzoe, Lorrin Pang, K Weerasuriya, A.D.M. Bryceson   +9 more
openalex  

Detection of amphotericin B-resistant Candida isolates in a broth-based system

, 1995
John Rex, Chester R. Cooper, William G. Merz, J N Galgiani, E. Anaissie   +4 more
openalex   +2 more sources

Isavuconazole-Amphotericin B and Isavuconazole-Caspofungin In Vitro Synergic Activity Against Invasive Pulmonary Aspergillosis Molds Isolates. [PDF]

Antibiotics (Basel)
Calvo M, Caruso M, Tempesta AA, Trovato L.   +3 more
europepmc   +1 more source

Comparison of Early Fungicidal Activity and Mortality Between Daily Liposomal Amphotericin B and Daily Amphotericin B Deoxycholate for Cryptococcal Meningitis. [PDF]

Clin Infect Dis
Kimuda S, Kwizera R, Dai B, Kigozi E, Kasozi D, Rutakingirwa MK, Tukundane A, Shifah N, Luggya T, Luswata A, Ndyetukira JF, Yueh SL, Mulwana S, Wele A, Bahr NC, Meya DB, Boulware DR, Skipper CP.   +17 more
europepmc   +1 more source

Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant <i>Candida parapsilosis</i> bloodstream infections. [PDF]

Antimicrob Agents Chemother
Vena A, Bartalucci C, Muccio M, Tiseo G, Muñoz P, Cesaretti M, Di Pilato V, Marchese A, Barbieri R, Forniti A, Giacobbe DR, Limongelli A, Lupetti A, Mikulska M, Salmanton-García J, Soriano Martín A, Taramasso L, Valerio M, Escribano P, Guinea J, Bouza E, Falcone M, Bassetti M, ESCMID Fungal Infection Study Group (EFISG).   +23 more
europepmc   +1 more source

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing. [PDF]

Clin Pharmacol Ther
Chu WY, Singh OP, Sundar S, Mondal D, Pandey K, Das P, Roseboom IC, Raja S, Torres A, Carrillo E, Huitema ADR, Alves F, Dorlo TPC.   +12 more
europepmc   +1 more source

Enhanced Antifungal Efficacy through Controlled Delivery of Amphotericin B Loaded in Polyetheramine-Epoxide Nanogels. [PDF]

ACS Polym Au
Reinaldi JS, Andrada HE, Cunha AFAP, Fico BA, Alves FB, P Orenha R, Parreira RLT, Pires RH, Vaca Chávez F, Tissera CE, Fernando Silva O, Fernandez MA, Passos AR, Molina EF.   +13 more
europepmc   +1 more source

Clove Oil-Based Nanoemulsion Containing Amphotericin B as a Therapeutic Approach to Combat Fungal Infections. [PDF]

Pharmaceutics
de Almeida ML, Matos APDS, Cardoso VDS, do Nascimento T, Santos-Oliveira R, Rocha LM, Machado FP, Kenechukwu FC, Vermelho AB, Ricci-Júnior E.   +9 more
europepmc   +1 more source